BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30638730)

  • 1. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
    Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
    J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist home visits: A 1-year experience from a community pharmacy.
    Monte SV; Passafiume SN; Kufel WD; Comerford P; Trzewieczynski DP; Andrus K; Brody PM
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):67-72. PubMed ID: 26802924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic viability of tech-check-tech in an independent community pharmacy.
    Gatwood J; Martin H; Newsome R; Hohmeier KC
    J Am Pharm Assoc (2003); 2019; 59(4):570-574. PubMed ID: 30979577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' barriers and facilitators on implementing a post-discharge home visit.
    Ensing HT; Koster ES; Sontoredjo TAA; van Dooren AA; Bouvy ML
    Res Social Adm Pharm; 2017; 13(4):811-819.e2. PubMed ID: 27663391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program.
    Ensing HT; Koster ES; Dubero DJ; van Dooren AA; Bouvy ML
    Res Social Adm Pharm; 2019 Mar; 15(3):267-278. PubMed ID: 29773308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of technician-driven medication therapy management program in community pharmacies.
    Burnside TPT; Scott NJ; Smith MG
    J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the economic impact of a targeted medication intervention program.
    Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
    J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived value of a home-based medication therapy management program for the elderly.
    Moultry AM; Poon IO
    Consult Pharm; 2008 Nov; 23(11):877-85. PubMed ID: 19072012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
    McDonough RP; Harthan AA; McLeese KE; Doucette WR
    J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
    Muraywid B; Butkievich LE; Myers B
    J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.